10:01 AM EST - Intellipharmaceutics International Inc. : announced that the United States Food and Drug Administration provided the Company with notification regarding its Investigational New Drug Application submission for Rexista™ Oxycodone XR (Abuse Deterrent oxycodone hydrochloride) extended release tablets. Intellipharmaceutics International Inc.
shares T.I are trading up $0.65 at $3.96.
